Central Trust Company’s Asensus Surgical, Inc. ASXC Stock Holding History

Central Trust Company’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-77	Closed	–	–	1146
2020 Q4	$0	Buy	+77	New	+$35	﹤0.01%	1111

Other funds holding ASXC

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Central Trust Company's ASXC Position: Q1 2021 in Review

Central Trust Company sold out of Asensus Surgical, Inc. (ASXC) in Q1 2021, closing a stake of 77 shares.

Central Trust Company first reported a position in ASXC in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 100 funds tracked by Wall St. Rank hold ASXC as of Q1 2021.

Central Trust Company reported no remaining Asensus Surgical, Inc. position as of Q1 2021 after selling out during the quarter.
Central Trust Company sold 77 Asensus Surgical, Inc. shares in Q1 2021.
Central Trust Company first reported a position in Asensus Surgical, Inc. in Q4 2020 and held it in 1 quarter.
Central Trust Company's Asensus Surgical, Inc. position peaked at $0 in Q4 2020.
100 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2021.

Based on Central Trust Company's 13F filing for Q1 2021, filed 23 Apr 2021.